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Purpose. The purpose of this pilot study was to determine if a difference existed between nosocomial pneumonia rates
for intubated critical care unit (CCU) patients who received twice-daily oral hygiene care with 0.12% chlorhexidine
gluconate and those who received the standard oral care.
Methods. Over seven months (February to August), CCU patients were identified through screening and informed
consent procedures, and randomized into1 of 2 groups. Over the 7 months, due to the critically ill nature of the patients,
only 5 subjects were enrolled. While in the study, twice-daily oral hygiene care consisted of brushing the cheeks, teeth,
and endotracheal tube with a suctioning toothbrush using an FDA-approved 0.12% chlorhexidine gluconate antimicrobial
agent with the experimental group (2 intubated patients in the CCU). The control group (3 intubated patients in the
CCU) received the standard oral care 6 times per day utilizing a soft foam swab and half strength hydrogen peroxide.
All oral care was performed by the nursing staff. The number of persons developing nosocomial pneumonia was
monitored until hospital discharge.
Results. Results revealed that 1 person out of 3 in the control group was discharged from the hospital with a diagnosis
of nosocomial (aspiration) pneumonia. Neither of the 2 subjects in the experimental group was diagnosed with nosocomial
pneumonia. Preliminary findings suggest that twice-daily oral hygiene care with 0.12% chlorhexidine gluconate may
reduce the risk of nosocomial pneumonia in intubated patients more than the 6-times daily standard oral care protocol.
The standard oral care protocol does not include the use of an FDA-approved antimicrobial solution. However, the
small size of the sample makes this finding inconclusive.
Conclusion. Twice-daily oral hygiene care with 0.12% chlorhexidine gluconate may hold promise as a nosocomial
pneumonia reduction strategy within hospital CCUs; however, its application requires further testing.




A systematic review of articles on risk factors for nosocomial bacterial pneumonia suggests the oral cavity as a reservoir
for nosocomial respiratory pathogens.1,2 The incidence of nosocomial pneumonia greatly increases morbidity and mortality
and the length and expense of hospitalizations among critical care unit (CCU) patients. Currently, nosocomial pneumonia
is the second most common nosocomial infection in the United States.3 At particular risk for hospital-acquired pneumonia
are CCU patients undergoing intubation for airway management (See Figure 1). This disease occurs in 20% to 25% of
patients treated with mechanical ventilation and is associated with a mortality rate of 50% to 80%.4
Current theories explaining this incidence center on sources of normal flora bacteria or nosocomial bacteria from the
hospital environment that colonize the patient and are then aspirated into the lungs.5,6 Although theories about these
mechanisms present strong cases for both nasopharyngeal and gastric colonization, this pilot study focused on the oral
environment as the source of bacterial inoculation.
Patients in CCU settings are predisposed to develop colonies of more virulent pathogens than found in the normal oral
environment of healthy people. Data supports an association between nosocomial pneumonia and poor oral health for
persons with chronic obstructive pulmonary disease (COPD), congestive heart failure, diabetes mellitus, age greater than
70, mechanical ventilations, history of smoking, previous antibiotic treatment, immunosupression, depressed consciousness,
cross-infections, internal tube feeding, gastroesophazeal reflux, a long preoperative stay, and/or prolonged surgical
procedures.1,2,7,8 Predisposing conditions such as mucosal desiccation, xerostomia, reduced immunoglobin, poor nutrition,
severe stress, intubation mechanical injury from nasogastricandeneo tracheal tubes, and a compromised immune system
allow respiratory bacteria to establish a population in the oral cavity. Rapid bacterial growth and mucosal adhesion occurs
on pharyngeal mucosa.5 These bacteria are then aspirated leading to life-threatening respiratory infection. Various methods
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of selective decontamination of the digestive tract using systemic and topical antibiotics have been studied with varying
success;9 however, broad use of antibiotic therapy increases patient risk of developing resistant bacterial strains.9 Hospitals
have implemented other strategies to reduce nosocomial pneumonia rates, such as meticulous handwashing by hospital
staff, early extubation, frequent suctioning of patients, and semi-Fowler's positioning of patients. Since current research
suggests that colonization of the oral cavity with respiratory pathogens precedes pulmonary colonization, the use of effective
oral hygiene protocols and antimicrobial products might provide a noninvasive, cost-effective method to decrease the
incidence of nosocomial pneumonia in the CCU environment.2,9
The original purpose of this study was to collect preliminary data on a protocol for oral decontamination of intubated
patients. The specific question addressed was: Does twice-daily oral hygiene care of intubated patients with 0.12%
chlorhexidine gluconate reduce the nosocomial pneumonia rate within a hospital CCU to a greater degree than the standard
oral care administered 6 times per day by the nursing staff? The exploratory hypothesis was:
Intubated patients who receive the twice-daily oral hygiene care with 0.12% chlorhexidine gluconate will experience a
lower incidence of nosocomial pneumonia compared to those who received the standard oral hygiene care 6 times per day,
as measured by overall nosocomial pneumonia rates. However, because of the small number of subjects enrolled, the
hypothesis could not be tested and the results are reported as a pilot study. See Table I for terms associated with this topic.
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Review of the Literature
Nosocomial pneumonia affects up to 40% of all critically ill or immunocompromised patients with fatality rates reported
ranging from 13% to 55%.10 Patients receiving mechanically-assisted ventilation have higher mortality rates than do
patients not receiving ventilation support;4 however, other factors such as the patient's underlying disease and organ failure
are stronger predictors of death in patients who have pneumonia.11 In addition, nosocomial pneumonia increases the time
required for hospitalization by 5 days to 7 days, resulting in increased hospital charges of approximately $1.3 billion per
year.3,12 Nosocomial pneumonia is a major infection control issue because of its reported frequency, high fatality rate, and
associated costs.7
The majority of nosocomial pneumonia cases are associated with extremes of age, underlying medical and respiratory
conditions, compromised immune systems, and trauma.13, 14 Intubation increases the risk of nosocomial infection because
it interferes with the body's initial reflexes to dispel aspirated bacteria.15 Intubation interferes with the body's cough reflex
and its mucociliary clearance; intubation also stimulates excess mucous secretions.3,13,15 Placement of an endotracheal tube
impairs the gag and cough reflexes that normally act to prevent organisms from entering the lower respiratory tract.13 In
addition, inspired air is no longer heated and humidified by the upper respiratory tract, but instead is artificially heated
and humidified by the ventilator. As a result, mucociliary clearance is impeded.10 In hospital settings, ventilator-associated
pneumonia usually occurs as a result of the colonization of microorganisms in the patient's oropharynx or gastrointestinal
tract at the time of admission or within a short time of admission.4
Numerous factors contribute to an unhealthy oral environment for an intubated patient: the patient's inability to perform
oral care; medications that cause xerostomia alter the body's host-response to infection or modify the normal bacterial
flora; presence of nasogastric and endotracheal tubing; trauma from the insertion of the endotracheal tube; lack of time
for oral care; and ineffective hand washing techniques by hospital staff.16-20 Such opportunities for contamination by the
oropharyngeal flora along with the microbial colonization of this compromised environment by more virulent pathogens
increases the probability for aspiration and subsequent infection in the lower respiratory tract.
Current evidence-based measures to control nosocomial pneumonia include disinfection of the hospital environment,
sterilization of critical care unit (CCU) equipment, pneumococcal vaccines, and education of all health care workers on
handwashing to further prevent cross-contamination of patients.21 Attention has also focused on decreasing the intubation
time, the continuous aspiration of subglottic secretions (CASS), and semi-Fowler's patient positioning. No clearly defined,
constantly used, evidence-based protocol has been developed for oral decontamination of intubated patients.19-20
Studies have looked at interventions to reduce the levels of oropharyngeal and gastrointestinal microorganisms, but most
methods utilize topical and systemic antibiotics termed selective decontamination of the digestive tract (SDD).22 The goal
of SDD is to reduce the number of microorganisms in the oropharynx and gastrointestinal tract; however, it may contribute
to antibiotic-resistant microorganisms and superinfections.23 One study could be found that tested the use of a topical
antimicrobial, such as 0.12% chlorhexidine gluconate, for oral decontamination of intubated patients.24 Twice-daily rinsing
with 0.12% chlorhexidine has been used successfully for many years in healthy patients to control dental plaque and
gingival inflammation.25 Chlorhexidine gluconate mouthrinse has been shown to be beneficial in reducing oral infections
and severe mucositis during cancer therapy,26 and to control oral soft tissue inflammation in patients with AIDS.27
Pneumonia may be caused by bacteria that are not normally residents of the oropharynx, but enter from the CCU
environment.1,9,24,28 The colonization of these microorganisms first takes place in the oropharynx with subsequent aspiration
into the lungs.1,12,21,24 If the oropharyngeal microorganisms are the primary contributors, then utilizing effective oral
antimicrobial decontamination twice-daily may decrease the risk of nosocomial pneumonia and decrease pneumonia rates
in CCU patients.24 Development of an effective oral hygiene protocol for intubated patients without the use of SDD could
feasibly provide a safe, efficient, and cost-effective way to diminish the morbidity, mortality, and expense of
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ventilator-associated pneumonia and nosocomial pneumonia in intensive care unit (ICU) patients.19,20,29 The oral care
protocol may also have implications for reducing respiratory infections in the elderly and in nursing home residents.13,14,30,31
Methods and Materials
Each orally and nasally intubated patient who entered the critical care unit (CCU) during the 7-month study had an
opportunity to participate, pending informed consent from the patient or legally authorized representative/ medical decision
maker. Many patients admitted to the CCU were unable to provide informed consent to participate. Upon admission,
potential subjects were screened to determine if it was possible for the subject to make the decision to participate, or if a
legally authorized representative or health care decision maker would make the decision. To minimize risks, approximately
20 potential subjects with the following characteristics were excluded from enrolling: currently taking metronidizole; a
history of allergy to chlorhexidine gluconate; sensitivity to alcohol; moderate or high risk for infective endocarditis;
congenital heart disease; a history of rheumatic fever or previous endocarditis; a surgically constructed pulmonary shunt;
hypertrophic cardiomyopathy; history of joint replacement within the past 2 years; history of previous joint infection; a
prosthetic heart valve; mitral valve prolapse; a joint replacement and immunosuppressed by medications taken for rheumatoid
arthritis; systemic lupus erythematosis; hemophilia; insulin dependent diabetes; uncontrolled diabetes; sickle cell anemia;
a ventriculoatrial shunt; and /or were admitted to the hospital with pneumonia and were subsequently intubated.
The original desired minimum sample size was 30 to 60, but this number depended on the number of intubated patients
who entered the CCU, met the inclusion criteria, and agreed to participate during the study period. At the completion of
the study in August 2002, only 5 patients had completed the study (N=5), although approximately 10 other patients met
enrollment criteria but declined to participate.
Subjects ranged in age from 28 years of age to 81 years of age. Four of 5 subjects were 50 years of age or older. One
hundred percent of the subjects were Caucasian. Two of the subjects were male and 3 of the subjects were female. These
5 patients were randomly assigned to either the control or experimental treatment by using the flip of a coin. A coin flipped
that landed on "heads" indicated that the patient be placed in the experimental group; "tails" indicated that the patients be
placed in the control group. Patients in the experimental group (n=2) received the twice-daily oral hygiene care with 0.12%
chlorhexidine gluconate during their intubation period. The patients in the control group (n=3) received the standard oral
care (Table II).
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The original plan was to utilize a randomized, 2 groups, post-test only experimental design. The 2 independent variables
included the twice-daily oral hygiene care with 0.12% chlorhexidine gluconate that the experimental group would receive
and the standard oral care that the control group would receive 6 times daily from the critical care nursing staff during
their entire intubation time. Twice daily administration of the experimental protocol was used because of the substantivity
of chlorhexidine, because dental patients are likely to clean their mouths morning and night, and to accommodate nursing
staff efficiencies. The outcome variable was the nosocomial pneumonia rate as determined by the attending physician and
recorded in patients' charts.
Although the structure of the study design remained intact, the investigation was modified to a case study due to the final
small sample size. Upon discharge, the nursing staff and principal investigator completed a demographic data sheet for
each of the 5 subjects enrolled in the study. This information was compiled to analyze the characteristics of the participants
in the sample descriptively.
The CCU nursing staff attended an educational session conducted by the 2 dental hygiene researchers on the twice-daily
oral hygiene protocol, recruited case study participants at the time of admittance to the critical care unit, provided the
twice-daily oral hygiene care protocol with chlorhexidine gluconate to the experimental group or the standard oral care
protocol that the hospital already followed to the control group, and kept a record of the oral hygiene administration and
adverse effects to the subjects.
The principal investigator visited the CCU every 3 days to 4 days to monitor record keeping and to note adverse effects.
No adverse effects were noted. The record of oral hygiene administration was kept with each patient's hospital chart. The
equipment and materials utilized for the twice-daily oral hygiene protocol in this study included the Plak-Vac™ Oral
Evacuator Brush distributed by Trademark Corporation (Figures 2 & 3) and 0.12% chlorhexidine gluconate distributed
by the Discus Dental Company. The materials utilized for the standard oral care protocol included a suctioning foam swab,
hydrogen peroxide, and oral lubricant (Figure 4).
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Nothing was requested of the eligible subjects except for their informed consent to receive a twice-daily oral hygiene care
regimen with chlorhexidine gluconate or the standard oral care protocol. No modifications were made in the nursing care
routine, other than the twice-daily oral hygiene care provided to the 2 intubated patients in the experimental group. Both
oral hygiene protocols were conducted for as long as the 5 intubated patients remained in the CCU. These intubated subjects
were a transient population to the CCU; none remained for the entire 7-month study period. The CCU nursing staff
monitored each subject for nosocomial pneumonia with a diagnosis made by a physician.
The small sample size prohibited the use of parametric statistical analysis and hypothesis testing; therefore, descriptive
statistics, in the form of frequencies, percentages, and measures of central tendency were used. Demographic data were
reported to thoroughly describe the patients in the study, to verify group equivalency, and to identify possible external
factors that might have influenced the development of nosocomial pneumonia.
Results
Upon discharge from the critical care unit (CCU), the nursing staff and principal investigator completed a demographic
data sheet for each of the 5 subjects enrolled in the study. Interestingly, one control group subject was diagnosed with
aspiration pneumonia. Males comprised 40% (n=2) of the sample, while women represented 60% (n=3) of the overall
sample population (Figure 5). Males comprised 67% (n=2) of the control group, while females comprised 33% (n=1) of
the control group and 100% (n=2) of the experimental group. Subjects ranged in age from 28 years of age to 81 year of
age (Figure 6). Four of the 5 subjects were 50+ years of age or older. The overall mean age of the subjects was 60.2 years.
The mean age of the experimental group was 40 years and the mean age of the control group was 73.7 years. The ethnic/racial
background of the subjects was 100 % Caucasian (N=5).
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The sizes of the endotracheal tubes for all subjects ranged from 7mm to 8 mm. One hundred percent (N=5) of the subjects
were orally intubated; 80% (n=4) had nasogastric tubes. The number of days spent at the hospital ranged from 9 days to
99 days, with a mean of 39.2 days from admission to discharge. The number of days spent in the CCU ranged from 3 days
to 33 days, with a mean of 13.4 days. The length of intubation time for the subject who developed nosocomial pneumonia
was 7 days. The number of days the control group (n=3) received the standard oral care ranged from 4 days to 7 days,
with a mean of 5 days (Figure 7). The number of days the experimental group (n=2) received the oral hygiene protocol
with 0.12% chlorhexidine gluconate ranged from 2 days to 9 days, with a mean of 5.5 days (Figure 8).
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Discussion
The exploratory hypothesis that intubated patients who receive the twice-daily oral hygiene care with 0.12% chlorhexidine
gluconate will experience less nosocomial pneumonia compared to those who received the standard oral care protocol, as
measured by overall nosocomial pneumonia rates could neither be rejected nor retained because no inferential statistical
analysis could be performed on data from only 5 subjects. However, the fact that one member of the control group developed
pneumonia deserves some explanation. Perhaps a contributing factor is that the subject was taking steroids, which can
mask the signs of infection, decrease the body's resistance to infection, and undermine the host-defense mechanism.32 The
subject was also taking an antibiotic, which can change the normal flora leading to a superinfection.3 Length of intubation
(7 days) may have played a role in the subject acquiring nosocomial pneumonia. According to Hixson et al33 the risk of
nosocomial pneumonia increased from 6.5% in those ventilated 10 days, to 28% in those ventilated 30 days. The longer
a patient is intubated, the greater the risk of a nosocomial pneumonia infection. The subject's diagnosis upon admission
to the hospital was respiratory failure, which is also a risk factor for the development of nosocomial pneumonia.29 The
patient was in the control group, which did not receive the 0.12% chlorhexidine gluconate with the Plak-Vac™ Oral
Evacuation Brush. The control group received oral hygiene care with a foam swab and hydrogen peroxide. However, a
toothbrush is a superior dental aid to a foam swab.34,35
The use of a 0.12% chlorhexidine gluconate mouthwash has been shown to greatly reduce the bacterial load in dental
plaque.24,25 DeRiso et al22 found that chlorhexidine gluconate reduced nosocomial pneumonia infection rates by 69%.
Overall, respiratory infection incidence of gram-negative bacteria was reduced by 67%.22 Perhaps not having the
chlorhexidine protocol further contributed to an already high-risk situation for the subject who developed nosocomial
pneumonia.
In hindsight, the stringent exclusionary criteria kept too many patients from qualifying for the study, impeding the
achievement of a large sample size. As reported by the critical care nursing staff, the patients admitted to the hospital CCU
have multiple and complex medical conditions. The primary exclusionary criteria that kept critical care unit patients from
qualifying for the study was a diagnosis of uncontrolled diabetes, closely followed by admission with pneumonia and
subsequent intubation. Also, given this high degree of medically complicated patients, family members and medical
decision-makers often were reluctant to consent to participation in the study. Many felt that their loved ones had been
through enough and viewed the study as an unnecessary intrusion.
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Demographically, the study sample comprised only Caucasian subjects. This lack of diversity does not favor the
generalization of the results to diverse cultural backgrounds. The sample was comprised of a larger proportion of females
(n=3). The majority of the subjects were over the age of 50 (n=4). Craven and Steger36 reported that host factors, such as
advanced age and underlying diseases, significantly increase the risk of pneumonia and colonization of the upper respiratory
tract, but are often not effective targets for prevention. Subjects in the control group were far older than the subjects in the
experimental group, which could also explain why one person in the control group developed nosocomial pneumonia.
Craven and Steger36 also suggest the placement of oral gastric tubes in place of nasogastric tubes to decrease the incidence
of nosocomial pneumonia. The subject in the control group who was discharged with a diagnosis of aspiration pneumonia
did have a nasogastric tube in place. This apparatus may have increased the subject's risk of acquiring the infection. The
serendipitous inclusion of the use of continuous suction endotracheal tubes for continuous aspiration of subglottic secretions
(CASS) in the CCU may have confounded the study and reduced nosocomial pneumonia rates. CASS has been shown
through previous research to be an effective component in the fight again nosocomial pneumonia.37,38 Fortunately, this
new procedure was used in all the subjects in the case study and therefore its effects were balanced across both experimental
and control groups.
Serendipitously, the nurses provided some feedback on their views of the experimental protocol. They noted that the
gingival tissues of the experimental group subjects appeared healthier, with less redness and reduced mouth debris. They
also felt the Plak-Vac™ Oral Evacuator Brush and chlorhexidine gluconate were easier and less time consuming to use
than the standard oral care protocol they currently utilize.
The nursing staff also expressed that the complex medical conditions of the patient population at the hospital CCU were
not conducive to subject enrollment. The exclusionary criterion, diabetes, should not have been used because most critically
ill patients experience changes in their blood glucose levels temporarily while in the hospital. A reported nursing staff
shortage interfered with having a clinical nurse specialist on site who could focus on subject screening, informed consent
procedures, and oral hygiene administration. These limitations may also have negatively affected the sample size.
Conclusions and Recommendations
The most important finding of the case study was that no subjects receiving the experimental treatment were diagnosed
with nosocomial pneumonia; however, one subject receiving the standard oral care did have an affirmative diagnosis of
nosocomial pneumonia upon discharge from the hospital. Results, although inconclusive because of the small sample size
and case study format, suggest that the twice-daily oral hygiene care of intubated patients with 0.12% chlorhexidine
gluconate may hold promise as a nosocomial pneumonia reduction strategy within a hospital critical care unit (CCU);
however, its application requires further testing.
Recommendations for future studies include the use of 0.12% chlorhexidine gluconate at multiple hospital-based sites so
that the sample size and diversity can be increased and the findings can be generalized. Furthermore, instead of recruiting
patients from the CCU, patients could be recruited in the step down unit or a department where patients have less complex
medical conditions. Utilizing a patient population with less complex medical conditions would increase the number of
eligible subjects and hence, the number of subjects enrolled, making the study more valid and reliable. Also, a hospital-based
person specifically paid to recruit patients on a daily basis is needed for future research in this area. The utilization of a
pre-procedural rinse with 0.12% chlorhexidine gluconate before endotracheal tube placement to reduce nosocomial
pneumonia risk needs further study. Future research would also need to address the question of whether the reduction in
nosocomial pneumonia rates came primarily from the 0.12% chlorhexidine gluconate mouthrinse or from the suctioning
of oral secretions and mouth debris by the Plak-Vac™ Oral Evacuator Brush. Preliminary data warrant further investigation.
Given the nursing shortage, if mouthcare by nurses can be reduced from 6 times per day to twice daily, then the hospital
is likely to accrue savings in personnel time and mouth care supplies.
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